Asthma forward hero graphic

Welcome to Asthma Forward

Our website is dedicated to providing you with the highest quality scientific information surrounding the treatment and clinical management of moderate to severe asthma, delivered in response to your questions.

Key areas

Unmet Need

Asthma remains a serious health risk in the US1. In this section you will find information on the unmet need for more effective asthma treatments for the many patients still experiencing burdensome symptoms despite ICS/LABA treatment.

Find out more

Role of LAMA

LAMAs have an important role in tackling undertreated bronchoconstriction in asthma. In this section you will find more information on the role of LAMA and how combining ICS/LABA/LAMA therapies provides dual bronchodilation and promotes an anti-inflammatory effect in the airways.

Find out more

Use of Triple Therapy

The CAPTAIN study provides robust evidence to support, and better tailor, the use of triple therapy using a treatable-traits-based approach. In this section you will find more information on how the CAPTAIN study supports the use of triple therapy in asthma.

Find out more

Broader Perspectives

Guidance-based care of uncontrolled asthma despite ICS/LABA requires an individualized approach. In this section you will find information on the practical considerations for step-up therapy in asthma.

Find out more

Featured content

Video graphic

What is the role of LAMA?

LAMAs and LABAs have complementary mechanisms of action to tackle undertreated bronchoconstriction…

Find Out More

article-large-article-teaser-image-asthma-forward-presentation-graphic

How does the CAPTAIN study support the use of triple therapy in asthma?

CAPTAIN provides robust evidence to support, and better tailor, the use of FF 100/UMEC/VI and FF 200/UMEC/VI using a treatable traits-based approach…

Find Out More

Latest content

Video graphic

Commonly asked questions

Using data from the CAPTAIN study, Professor Barnes and Dr Leather answer common questions about the role of LAMA in the treatment of asthma…

Find Out More

Poster graphic

CHEST 2023: Reduction of asthma exacerbations following initiation of…

The CHEST 2023 Annual Meeting took place October 8–11, 2023 in Honolulu, Hawai’i, United…

Find Out More

Congress highlights graphic

ERS 2023 International Congress Asthma Highlights

The ERS 2023 international congress took place 9–13 September, 2023 in Milan, Italy…

Find Out More

Reference

  1. Centers for Disease Control and Prevention (CDC). Most recent national asthma data. Last updated March 24, 2020. Accessed June 12, 2020.

Asthma Forward is a registered trademark of the GSK group of companies.
©2023 GSK group of companies. All rights reserved.

SE-GBL-FVU-WCNT-200018 | Date of preparation: October 2023